InVivo Therapeutics Holdings Corp. Daily Stock Analysis

Daily Stock Analysis, NVIV, InVivo Therapeutics Holdings Corp, priceseries

InVivo Therapeutics Holdings Corp. Daily Stock Analysis
Stock Information
Open
0.29
Close
0.29
High
0.31
Low
0.26
Previous Close
0.29
Daily Price Gain
0.00
YTD High
0.55
YTD High Date
Jan 4, 2022
YTD Low
0.26
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.24
YTD Gain
-45.09%
52 Week High
1.41
52 Week High Date
Mar 11, 2021
52 Week Low
0.26
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-0.72
52 Week Gain
-71.19%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 19. 2017
1800.00
Jun 23. 2017
2034.38
4 Trading Days
13.02%
Link
LONG
Sep 13. 2017
900.00
Oct 9. 2017
1115.29
18 Trading Days
23.92%
Link
LONG
Sep 27. 2018
61.80
Sep 28. 2018
65.08
1 Trading Days
5.31%
Link
LONG
Dec 26. 2019
4.98
Jan 2. 2020
5.84
4 Trading Days
17.14%
Link
LONG
Jan 3. 2020
7.05
Jan 15. 2020
8.04
8 Trading Days
14.01%
Link
LONG
Jan 20. 2021
1.20
Jan 27. 2021
1.32
5 Trading Days
10.00%
Link
LONG
Feb 3. 2021
1.30
Feb 19. 2021
1.58
11 Trading Days
21.55%
Link
Company Information
Stock Symbol
NVIV
Exchange
NasdaqGM
Company URL
http://www.invivotherapeutics.com
Company Phone
617-863-5524
CEO
Mark D. Perrin
Headquarters
Massachusetts
Business Address
ONE KENDALL SQUARE, BUILDING 1400 EAST 4TH FLOOR, CAMBRIDGE, MA 02139
Sector
-
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001292519
About

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which focuses on the treatment of spinal cord injuries. Its treatment approach is the Neuro-Spinal Scaffold implant, which is designed for implantation at the site of injury within a spinal cord and is intended to treat acute SCI. The company was founded by Joseph P. Vacanti, Frank M. Reynolds and Robert Langer on November 28, 2005 and is headquartered in Cambridge, MA.

Description

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI; and Therapeutic Trails injection program for the treatment of chronic SCI. The company was founded in 2005 and is based in Cambridge, Massachusetts.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading